Immunohistochemical analysis (Figure 3A) showed that NLRP3, ASC, and Caspase 1 protein expression was suppressed in organ cultures from IBD patients treated with either allopurinol or febuxostat in a dose-dependent manner as compared to those left untreated (DMSO vehicle only). This evidence concerns the gene CASP1 and inflammatory bowel disease.